PT980254E - Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral - Google Patents

Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral

Info

Publication number
PT980254E
PT980254E PT98925588T PT98925588T PT980254E PT 980254 E PT980254 E PT 980254E PT 98925588 T PT98925588 T PT 98925588T PT 98925588 T PT98925588 T PT 98925588T PT 980254 E PT980254 E PT 980254E
Authority
PT
Portugal
Prior art keywords
viral
glycyclic
comprehending
acid
pharmaceutical composition
Prior art date
Application number
PT98925588T
Other languages
English (en)
Inventor
Raffaello Pompei
Mario Pinza
Original Assignee
Aziende Chimiche R A Francesco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche R A Francesco filed Critical Aziende Chimiche R A Francesco
Publication of PT980254E publication Critical patent/PT980254E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98925588T 1997-05-14 1998-05-06 Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral PT980254E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale

Publications (1)

Publication Number Publication Date
PT980254E true PT980254E (pt) 2002-07-31

Family

ID=11377123

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98925588T PT980254E (pt) 1997-05-14 1998-05-06 Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral

Country Status (27)

Country Link
US (1) US6329339B1 (pt)
EP (1) EP0980254B1 (pt)
JP (2) JP2001525814A (pt)
KR (1) KR100592193B1 (pt)
CN (1) CN1114447C (pt)
AR (1) AR012849A1 (pt)
AT (1) ATE212232T1 (pt)
AU (1) AU740944B2 (pt)
BG (1) BG64748B1 (pt)
CA (1) CA2289550A1 (pt)
CZ (1) CZ291932B6 (pt)
DE (1) DE69803565T2 (pt)
DK (1) DK0980254T3 (pt)
EA (1) EA003126B1 (pt)
ES (1) ES2170501T3 (pt)
GE (1) GEP20022672B (pt)
HK (1) HK1028347A1 (pt)
HU (1) HU224956B1 (pt)
IL (2) IL132651A0 (pt)
IT (1) IT1291366B1 (pt)
PL (1) PL189218B1 (pt)
PT (1) PT980254E (pt)
SK (1) SK283584B6 (pt)
TR (1) TR199902730T2 (pt)
UA (1) UA63955C2 (pt)
WO (1) WO1998051334A1 (pt)
ZA (1) ZA983917B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
EP1499341A4 (en) * 2002-04-18 2010-10-27 Univ Iowa Res Found PROCESS FOR INHIBITING AND PROCESSING BIOLOGICAL FILMS USING METAL CHELATORS
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
AU2004272607B2 (en) * 2003-09-11 2008-11-06 Cornerstone Therapeutics Inc. Monoclonal antibodies against HMGB1
EP1909834A2 (en) * 2005-07-18 2008-04-16 Critical Therapeutics, Inc. Use of hmgb1 antagonists for the treatment of inflammatory skin conditions
EP1959997A4 (en) * 2005-11-28 2009-12-23 Medimmune Llc ANTAGONISTS OF HMGB1 AND / OR RAGE AND METHOD OF USE THEREOF
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
WO2012026928A1 (en) * 2010-08-25 2012-03-01 Diacarta Llc Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
JP5806434B1 (ja) 2014-02-21 2015-11-10 国立大学法人東京海洋大学 ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤
CN117942405A (zh) * 2016-02-25 2024-04-30 应用生物实验室公司 保护空气传播的病原体和刺激物的组合物和方法
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
EP4144363A4 (en) * 2020-04-27 2024-05-29 Guangzhou Century Clinical Research Co., Ltd MEDICINES, FOOD AND USE OF ANTI-CORONAVIRUS INFECTION
US20220305092A1 (en) * 2020-04-27 2022-09-29 Guangzhou Century Clinical Research Co., Ltd Medicament and food for preventing or treating novel coronavirus pneumonia covid-19 and use thereof
MX2021005280A (es) * 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
TR199902730T2 (xx) 2000-02-21
KR100592193B1 (ko) 2006-06-23
US6329339B1 (en) 2001-12-11
BG103968A (en) 2000-07-31
JP2001525814A (ja) 2001-12-11
DE69803565D1 (de) 2002-03-14
ES2170501T3 (es) 2002-08-01
ITMI971119A1 (it) 1998-11-14
HU224956B1 (en) 2006-04-28
AU7764698A (en) 1998-12-08
CZ399199A3 (cs) 2000-04-12
IL132651A0 (en) 2001-03-19
SK154499A3 (en) 2000-08-14
SK283584B6 (sk) 2003-10-07
EA199901024A1 (ru) 2000-06-26
HUP0002985A3 (en) 2001-04-28
JP2009102370A (ja) 2009-05-14
KR20010012419A (ko) 2001-02-15
HUP0002985A2 (hu) 2001-01-29
HK1028347A1 (en) 2001-02-16
EP0980254B1 (en) 2002-01-23
DE69803565T2 (de) 2002-08-08
WO1998051334A1 (en) 1998-11-19
ATE212232T1 (de) 2002-02-15
GEP20022672B (en) 2002-04-25
PL336802A1 (en) 2000-07-17
IL132651A (en) 2006-10-31
AU740944B2 (en) 2001-11-15
CZ291932B6 (cs) 2003-06-18
CN1114447C (zh) 2003-07-16
AR012849A1 (es) 2000-11-22
IT1291366B1 (it) 1999-01-07
CA2289550A1 (en) 1998-11-19
CN1255859A (zh) 2000-06-07
ITMI971119A0 (pt) 1997-05-14
BG64748B1 (bg) 2006-02-28
PL189218B1 (pl) 2005-07-29
EA003126B1 (ru) 2003-02-27
UA63955C2 (uk) 2004-02-16
DK0980254T3 (da) 2002-05-06
ZA983917B (en) 1998-11-09
EP0980254A1 (en) 2000-02-23

Similar Documents

Publication Publication Date Title
PT980254E (pt) Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral
BR9702808A (pt) Utilização de pelo menos um retinóide apresentando uma atividade anti-ap-1
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
IT8519353A0 (it) Composizione farmaceutica e forme farmaceutiche che la contengono
BR1100824A (pt) Composto e composição farmacêutica
ID30181A (id) Asam antranilat- dan asam tioantranilat-n-aril amida
FI944832A0 (fi) Farmaseuttinen koostumus
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
NO20002038D0 (no) Uløselig insulinsammensetning
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
ITMI962505A0 (it) Nuovi esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
ITMI932540A0 (it) Composizione farmaceutica
BR9509688A (pt) Composto e composição farmacêutica
DE69527764T2 (de) Backtriebsäurezusammensetzung
ID29294A (id) Komposisi farmasi
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
LV10579A (lv) Farmaceitiska kompozicija
ATA231194A (de) Häcksler
ID23531A (id) Komposisi farmasi
BR9505130A (pt) Composto e composiçao farmacêutica
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.
BR1100391A (pt) Composto e composição farmacêutica
ITMI921253A1 (it) Composizione farmaceutica avente attivita' antivirale